This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Published Erratum

. 2025 Jan 21;151(3):e30.

doi: 10.1161/CIR.0000000000001302. Epub 2025 Jan 21.

Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation

No authors listed

PMID: 39836761
DOI: 10.1161/CIR.0000000000001302

Free article

Published Erratum

Correction to: Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation

No authors listed. Circulation. 2025.

Free article

. 2025 Jan 21;151(3):e30.

doi: 10.1161/CIR.0000000000001302. Epub 2025 Jan 21.

PMID: 39836761
DOI: 10.1161/CIR.0000000000001302

No abstract available

PubMed Disclaimer

Erratum for

Comparative Cardiovascular Effectiveness of Empagliflozin Versus Dapagliflozin in Adults With Treated Type 2 Diabetes: A Target Trial Emulation.
Bonnesen K, Heide-Jørgensen U, Christensen DH, Lash TL, Hennessy S, Matthews A, Pedersen L, Thomsen RW, Schmidt M. Bonnesen K, et al. Circulation. 2024 Oct 29;150(18):1401-1411. doi: 10.1161/CIRCULATIONAHA.124.068613. Epub 2024 Aug 29. Circulation. 2024. PMID: 39206550

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.